Journal of Pediatric Health Care
Volume 21, Issue 2 , Pages 139-141 , March 2007

When Urine pH Really Matters

  • Andrea Lynne Parker, MSN, RN, CPNP-AC

      Affiliations

    • Andrea Lynne Parker is Staff Nurse, Emergency Department, Children’s Hospital Los Angeles, Los Angeles, Calif.
    • Corresponding Author InformationCorrespondence: Andrea Lynne Parker, MSN, RN, CPNP-AC, Emergency Department, Children’s Hospital Los Angeles, 4650 Sunset Blvd, Los Angeles, CA 90027.

References 

  1. Haas NA, et al. Successful management of an extreme example of neonatal hyperprostaglandin-E syndrome (Bartter’s syndrome) with the new cyclooxygenase-2 inhibitor rofecoxib. Pediatric Critical Care Medicine. 2003;4(2):249–251
  2. Hay WW, Levin MJ, Sondheimer JM, Deterding RR. Current pediatric diagnosis and treatment. (17th ed.). New York: Lange Medical Books/McGraw-Hill; 2005;
  3. Lin J. Renal Tubular Acidosis. In:  Perkin RM,  Swift JD,  Newton DA editor. Pediatric Hospital Medicine: Textbook of Inpatient Management. Philadelphia: Lippincott, Williams & Wilkins; 2003;p. 399–401
  4. Janik JE, Bloch CA, Janik JS. Intrathyroid parathyroid gland and neonatal primary hyperparathyroidism. Journal of Pediatric Surgery. 2000;35(10):1517–1519
  5. Kelepouris E, Agus ZS. Overview of renal tubular acidosis. 2003;(April 4). Retrieved from http://www.uptodate.com
  6. Pediatric Lexi-Drugs. File Date: Dec 5, 2005. [Computer software]. Authorized by Lexi-Comp.
  7. Rose BD. Etiology and diagnosis of type 1 and type 2 renal tubular acidosis. 2006;(January 10). Retrieved from http://www.uptodate.com

PII: S0891-5245(06)00790-5

doi: 10.1016/j.pedhc.2006.12.012

Journal of Pediatric Health Care
Volume 21, Issue 2 , Pages 139-141 , March 2007

Article Tools